132 related articles for article (PubMed ID: 11467650)
1. B2 microglobulin: is it a reliable marker of activity in inflammatory bowel disease?
Zissis M; Afroudakis A; Galanopoulos G; Palermos L; Boura X; Michopoulos S; Archimandritis A
Am J Gastroenterol; 2001 Jul; 96(7):2177-83. PubMed ID: 11467650
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
Vucelic B
Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
4. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
5. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
[TBL] [Abstract][Full Text] [Related]
6. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
8. Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease.
Yılmaz B; Köklü S; Yüksel O; Arslan S
World J Gastroenterol; 2014 Aug; 20(31):10916-20. PubMed ID: 25152594
[TBL] [Abstract][Full Text] [Related]
9. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
[TBL] [Abstract][Full Text] [Related]
10. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
[TBL] [Abstract][Full Text] [Related]
11. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease.
Gouni-Berthold I; Baumeister B; Berthold HK; Schmidt C
Hepatogastroenterology; 1999; 46(27):1720-3. PubMed ID: 10430330
[TBL] [Abstract][Full Text] [Related]
14. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease.
Shinzaki S; Iijima H; Nakagawa T; Egawa S; Nakajima S; Ishii S; Irie T; Kakiuchi Y; Nishida T; Yasumaru M; Kanto T; Tsujii M; Tsuji S; Mizushima T; Yoshihara H; Kondo A; Miyoshi E; Hayashi N
Am J Gastroenterol; 2008 May; 103(5):1173-81. PubMed ID: 18177457
[TBL] [Abstract][Full Text] [Related]
15. Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease.
Koutroubakis IE; Xidakis C; Karmiris K; Sfiridaki A; Kandidaki E; Kouroumalis EA
Eur J Clin Invest; 2006 Feb; 36(2):127-32. PubMed ID: 16436095
[TBL] [Abstract][Full Text] [Related]
16. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
Becker K; Niederau C; Frieling T
Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
[TBL] [Abstract][Full Text] [Related]
17. Elevated thrombopoietin serum levels in patients with inflammatory bowel disease.
Kapsoritakis AN; Potamianos SP; Sfiridaki AI; Koukourakis MI; Koutroubakis IE; Roussomoustakaki MI; Manousos ON; Kouroumalis EA
Am J Gastroenterol; 2000 Dec; 95(12):3478-81. PubMed ID: 11151880
[TBL] [Abstract][Full Text] [Related]
18. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity.
Clara I; Lix LM; Walker JR; Graff LA; Miller N; Rogala L; Rawsthorne P; Bernstein CN
Am J Gastroenterol; 2009 Jul; 104(7):1754-63. PubMed ID: 19455122
[TBL] [Abstract][Full Text] [Related]
19. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
[TBL] [Abstract][Full Text] [Related]
20. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
